| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 112,840 | $1 | $451.4K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11,150 | $30 | $379.1K |
| J3262 | Injection, tocilizumab, 1 mg | 48,990 | $10 | $244.9K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,860 | $30 | $100.4K |
| J0897 | Injection, denosumab, 1 mg | 4,920 | $20 | $88.6K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 10,500 | $10 | $84K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 740 | $70 | $55K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 900 | $50 | $42.1K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 370 | $80 | $30.5K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 80 | $140 | $10.4K |